ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,340Medicare Part D Prescriptions Filled, Including Refills

Rank: 676 out of 2094

$326K Total Retail Price of All Prescriptions

Rank: 937 out of 2094

141 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 141 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 141 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 4,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 204 191 1 2
MIRTAZAPINE 201 195 2 43
LEVOTHYROXINE SODIUM 144 90 3 3
OXYCODONE-ACETAMINOPHEN 139 96 S2 4 40
FUROSEMIDE 133 115 5 6
SIMVASTATIN 128 103 6 1
POTASSIUM CHLORIDE 122 122 7 24
METOPROLOL TARTRATE 118 113 8 10
QUETIAPINE FUMARATE 113 59 9 71
WARFARIN SODIUM 113 99 9 11
ATORVASTATIN CALCIUM 108 101 11 5
OMEPRAZOLE 100 95 12 4
LISINOPRIL 97 61 13 7
GABAPENTIN 92 80 14 23
ESCITALOPRAM OXALATE 91 70 15 46
DIVALPROEX SODIUM 88 46 16 69
DONEPEZIL HCL 87 87 17 20
FAMOTIDINE 82 80 18 34
ZOLPIDEM TARTRATE 74 29 19 14
METOPROLOL SUCCINATE 72 60 20 9
DIOVAN 71 49 21 13
IPRATROPIUM-ALBUTEROL 69 67 22 92
SERTRALINE HCL 66 59 23 26
PANTOPRAZOLE SODIUM 65 52 24 37
LIDODERM 65 63 24 59
LEVETIRACETAM 63 52 26 78
FENTANYL 58 30 S2 27 68
SEROQUEL 55 38 28 172
HYDROCHLOROTHIAZIDE 55 54 28 12
LOSARTAN POTASSIUM 51 51 30 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.